Article Versions Notes

Elkamhawy A, Ammar UM, Paik S, Abdellattif MH, Elsherbeny MH, Lee K, Roh EJ. Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening. Molecules. 2021; 26(17):5324. https://doi.org/10.3390/molecules26175324

Elkamhawy, Ahmed, Usama M. Ammar, Sora Paik, Magda H. Abdellattif, Mohamed H. Elsherbeny, Kyeong Lee, and Eun Joo Roh. 2021. "Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening" Molecules 26, no. 17: 5324. https://doi.org/10.3390/molecules26175324

Elkamhawy, A., Ammar, U. M., Paik, S., Abdellattif, M. H., Elsherbeny, M. H., Lee, K., & Roh, E. J. (2021). Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening. Molecules, 26(17), 5324. https://doi.org/10.3390/molecules26175324